Abstract
Data from a population-based prospective study were used to examine longitudinal changes in blood pressure (BP) and seek interactions between apolipoprotein E (ApoE) genotypes, smoking and alcohol in a cohort of 557 elderly Brazilian men. Repeated BP measurements were obtained in four waves, and multi-level random-effects pattern-mixture models were used to evaluate age-related BP trajectories while accounting for non-ignorable dropouts/deaths and handling heterogeneities as random parameter variations. Alcohol was associated with high systolic BP in ɛ2 carriers and those with the ɛ3/3 genotype, but not in ɛ4 carriers. This was dependent on age and smoking habits: at the age of 60, expected systolic BP in alcohol drinking ɛ2 carriers was 16.5 mm Hg higher than in the reference group of non-smokers/non-drinkers if they were not smokers (P=0.049), and 28.6 mm Hg higher if they were also smokers (P=0.004). The youngest smoking/non-drinking ɛ2 carriers had lower systolic BP, but it increased rapidly and led to higher expected levels among older carriers. Alcohol consumption, alone or together with smoking, interacts with the effects of ApoE genotype on systolic BP, probably nullifying the more favourable lipid profile of ɛ2 carriers. The interactions of gene-modifiable risk factors have major public health implications.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pausova Z, Tramblay J, Hamet P . Gene–environment interactions in hypertension. Cur Hypertens Rep 1999; 1: 42–50.
Kodavali L, Townsend RR . Alcohol and its relationship to blood pressure. Cur Hypertens Rep 2006; 8: 338–344.
Primatesta P, Falaschetti E, Gupta S, Marmot MG, Poulter NR . Association between smoking and blood pressure. Evidence from the health survey for England. Hypertension 2001; 37: 187–193.
Mahley RW, Rall SC . Apolipoprotein E: Far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000; 1: 507–537.
Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007; 298: 1300–1311.
Marques-Vidal P, Bongard V, Ruidavets J-B, Fauvel J, Hanaire-Broutin H, Perret B et al. Obesity and alcohol modulate the effect of apolipoprotein E polymorphism on lipids and insulin. Obes Res 2003; 11: 1200–1206.
Talmud PJ, Stephens JW, Hawe E, Demissie S, Cupples LA, Hurel SJ et al. The significant increase in cardiovascular disease risk in ApoE ɛ4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. Ann Hum Genet 2005; 69: 613–622.
Hamet P . Apolipoprotein E alleles and hypertension: controversy or lack of understanding? J Hypertens 2002; 20: 1941–1942.
Kauma H, Savolainen MJ, Rantala AO, Lilja M, Kervinen K, Reunanen A et al. Apolipoprotein E phenotype determines the effect of alcohol on blood pressure in middle-aged men. Am J Hypertens 1998; 11: 1334–1343.
Correa Leite ML, Lima-Costa MF, Moriguchi EH . Age-related trends of blood pressure levels by apolipoprotein E genotype: the Bambuì cohort study of ageing (1997–2008). Hypertens Res 2013; 36: 270–276.
Lima-Costa MF, Firmo JOA, Uchoa E . The Bambuì Cohort Study of Ageing: methodology and health profile of participants at baseline. Cad Saude Publica 2011; 27 (Suppl 3): S327–S335.
Hixson JE, Vernier DT . Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990; 31: 545–548.
WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2010. Oslo 2009 282 p. Available from http://www.whocc.no/filearchive/publications/2010guidelines.pdf.
Hedeker D, Gibbons RD . Application of random-effects pattern-mixture models for missing data in longitudinal studies. Psychol Methods 1997; 2: 64–78.
StataCorp. 2009. Stata: Release 11. Statistical Software. College Station, TX: StataCorp LP.
Manolio TA, Bailey-Wilson JE, Collins FS . Genes, environment and the value of prospective cohort studies. Nature Rev Genet 2006; 7: 812–820.
Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 1999; 150: 341–353.
Klatsky AL, Gunderson E . Alcohol and hypertension: a review. J Am Soc Hypertens 2008; 2: 307–317.
Sesso HD, Cook NR, Buring JE, Manson JE, Gaziano JM . Alcohol consumption and the risk of hypertension in women and men. Hypertension 2008; 51: 1080–1087.
McEniery CM, Spratt M, Munnery M, Yarnell J, Lowe GD, Rumley A et al. An analysis of prospective risk factors for aortic stiffness in men: 20-year follow-up from the Caerphilly prospective study. Hypertension 2010; 56: 36–43.
Weintraub MS, Eisenberg S, Breslow JL . Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987; 80: 1571–1577.
Hartung GH, Lawrence SJ, Reeves RS, Foreyt JP . Effect of alcohol and exercise on postprandial lipemia and triglyceride clearance in men. Atherosclerosis 1993; 100: 33–40.
Ginsberg H, Olefsky J, Farquhar JW, Reaven GM . Moderate ethanol ingestion and plasma triglyceride levels: a study in normal and hypertriglyceridemic persons. Ann Intern Med 1974; 80: 143–149.
Van de Wiel A . The effect of alcohol on postprandial and fasting triglycerides. Int J Vasc Med 2012; 2012: 862504.
Nestel PJ, Shige H, Pomeroy S, Cehun M, Chin-Dusting J . Post-prandial remnant lipids impair arterial compliance. J Am Coll Cardiol 2001; 37: 1929–1935.
Jagla A, Schrezenmeir J . Postprandial triglycerides and endothelial function. Exp Clin Endocrinol Diabetes 2001; 109: S533–S547.
Kabagambe EK, Ordovas JM, Tsai MY, Borecki IB, Hopking PN, Blasser SP et al. Smoking, inflammatory patterns and postprandial hypertriglyceridemia. Atherosclerosis 2009; 203: 633–639.
Leone A . Does smoking act as a friend or enemy of blood pressure? Let release Pandora’s box. Cardiol Res Pract 2011; 2011: 264894.
Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN et al. Triglycerides and cardiovascular disease. A scientific statement from the American Heart Association. Circulation 2011; 123: 2292–2333.
Mayer O, Filipovsky J, Pesta M, Cifkova R, Dolejsova M, Simon J . The interaction of endothelial nitric oxide synthase polymorphism and current smoking in terms of increased arterial stiffness. Physiol Res 2010; 59: 529–536.
Gustavsson J, Mehlig K, Leander K, Strandhagen E, Bjorck L, Thelle DS et al. Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women. Atherosclerosis 2012; 220: 486–492.
Karvonen J, Kauma H, Kervinen K, Ukkola O, Rantala M, Paivansalo M et al. Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men. J Hypertens 2002; 20: 2372–2378.
Bohnet K, Regis-Bailly A, Vincent-Viry M, Schlenck A, Gueguen R, Siest G et al. Apolipoprotein E genotype epsilon 4/epsilon 2 in the STANISLAS Cohort Study: dominance of the epsilon 2 allele? Ann Hum Genet 1996; 60: 509–516.
Woo D, Haverbusch M, Sekar P, Kissela B, Khoury J, Schneider A et al. Effect of untreated hypertension on hemorrhagic stroke. Stroke 2004; 35: 1703–1708.
Kagan A, Yano K, Rhoads GG, McGee DL . Alcohol and cardiovascular disease: the Hawaiian experience. Circulation 1981; 64 (Suppl III): 27–31.
Chowdhury AH, Yokoyama T, Kokubo Y, Zaman MM, Haque A, Tanaka H . Apolipoprotein E genetic polymorphism and stroke subtypes in a Bangladeshi hospital-based study. J Epidemiol 2001; 11: 131–138.
Anuurad E, Rubin J, Lu G, Pearson TA, Holleran S, Ramakrishnan R et al. Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol. J Lipid Res 2006; 47: 2475–2481.
Acknowledgements
We thank Dr M Taufer (CMIC Brazil Clinical Research Laboratory, Porto Alegre, Brazil) for genotyping ApoE. This study was supported by a grant from the Italian National Research Council (CNR) in the ambit of the Bilateral Agreement of Scientific Cooperation CNR-CNPq (Brazil).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Leite, M., Moriguchi, E. & Lima-Costa, M. Interactive effects of ApoE polymorphism, alcohol and smoking on age-related trends of blood pressure levels in elderly men: the Bambuì Cohort Study of Ageing (1997–2008). J Hum Hypertens 27, 497–503 (2013). https://doi.org/10.1038/jhh.2012.70
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2012.70